Priority Date: 10.02.17 (US 201762457422P)

IFN- -INDUCIBLE REGULATORY T CELL CONVERTIBLE ANTI-CANCER (IRTCA) ANTIBODY AND USES THEREOF

  • Application ID: EP18751349
  • Status: Request for examination was made

Attorney

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.02.2017 - Priority Date (US 201762457422P)
  • 16.08.2018 - Publication A1 (WO2018146549)
  • 24.04.2019 - Publication A1 (EP3472209)